CHOROIDEREMIA RESEARCH FOUNDATION INC (EIN 043511754) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

Kathi Wagner

Phone

8002100233

Tax Period

2024-07-01 to 2025-06-30

CHOROIDEREMIA RESEARCH FOUNDATION INC, founded in 2000, is a small nonprofit in the Science & Technology sector that reported $965K in total revenue in fiscal year 2024. Revenue surged 38% from the prior year, signaling strong growth momentum. The organization ran a surplus of $146K, a strong 15% operating margin.

Mission

To raise funds in support of scientific research leading to a treatment or cure of Choroideremia, a hereditary retinal-degenerative disease that causes blindness; to educate people affected by the disease and the public.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $932,115

Program Service Revenue $0

Investment Income $30,908

Other Revenue $1,814

TOTAL REVENUE $964,837

Expense Breakdown

Grants Paid $418,922

Salaries & Benefits $199,909

Fundraising Expenses $89,049

Program Expenses $656,983

Other Expenses $200,225

TOTAL EXPENSES $819,056

Year-over-Year Comparison

	2024	2023	Change
Revenue	$964,837	$699,069	+0.4%
Expenses	$819,056	$689,478	+0.2%
Net Income	$145,781	$9,591	+14.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

200

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KATHI WAGNER	EXECUTIVE DIRECTOR	40.00		$107,780	$0	$107,780
Neal Bench	President	1.00	Officer Director	$0	$0	$0
John Trott	Vice President	1.00	Officer Director	$0	$0	$0
Michael Mullen	Vice President	1.00	Officer Director	$0	$0	$0
Tara Cassidy-Driscoll	Director	1.00	Director	$0	$0	$0
Brian Mayer	Secretary	1.00	Officer Director	$0	$0	$0
Michael Laengsfeld	Director	1.00	Director	$0	$0	$0
Jason McKinney	Director	1.00	Director	$0	$0	$0
Dr John-Ross Rizzo	Director	1.00	Director	$0	$0	$0
Liza Zumsteg	Treasurer	1.00	Director	$0	$0	$0
Jon Salois	Director	1.00	Director	$0	$0	$0
Kayla Schiller	Treasurer	1.00	Officer Director	$0	$0	$0
Bob Hillier	DIRECTOR	1.00	Director	$0	$0	$0
Brian Counter	Director	1.00	Director	$0	$0	$0
Aurelie Harp	Director	1.00	Director	$0	$0	$0
Yamil Rosete-Rodriguez	Director	1.00	Director	$0	$0	$0
Sarah Thompson	Director	1.00	Director	$0	$0	$0
Mary Porter	Director	1.00	Director	$0	$0	$0
Rachel Oster	Director	1.00	Director	$0	$0	$0
Naama Goldman-Einhorn	Director	1.00	Director	$0	$0	$0
Thomas Driscoll	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$964,837	$819,056	$956,687	$145,781
2024	$699,069	$689,478	$810,811	$9,591
2023	$560,892	$745,500	$801,239	$-184,608
2022	$664,881	$584,677	$985,906	$80,204
2021	$672,399	$574,049	$905,807	$98,350
2020	$597,064	$640,929	$807,483	$-43,865
2019	$416,063	$399,240	$894,174	$16,823
2018	$531,038	$435,765	$833,614	$95,273

CHOROIDEREMIA RESEARCH FOUNDATION INC